Showing results (61-70 of 85) with videos related to
Sort By:
Pageof 9
Annals of Surgical Oncology|December 5, 2002
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV diseaseGarrett M Nash, Leonard B Saltz, Nancy E Kemeny, et al.Journal of Palliative Medicine|June 4, 2013
A randomized controlled trial of a cardiopulmonary resuscitation video in advance care planning for progressive pancreas and hepatobiliary cancer patientsAndrew S Epstein, Angelo E Volandes, Ling Y Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2019
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric CancerMegan Greally, Joanne F Chou, Walid K Chatila, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and RecommendationsZishuo I Hu, Jinru Shia, Zsofia K Stadler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2020
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 MutationEileen M O'Reilly, Jonathan W Lee, Mark Zalupski, et al.Cancer|October 7, 2015
Identification of germline genetic mutations in patients with pancreatic cancerErin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, et al.Cancer|June 1, 2022
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancerKenneth H Yu, Jennifer Park, Avni Mittal, et al.European Radiology|January 29, 2019
Pilot study of rapid MR pancreas screening for patients with BRCA mutationGiuseppe Corrias, Mitchell C Raeside, Andrea Agostini, et al.European Journal of Cancer (Oxford, England : 1990)|December 11, 2017
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinomaMaeve A Lowery, David P Kelsen, Marinela Capanu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Efficacy of Combined VEGFR1-3, PDGFα/β, and FGFR1-3 Blockade Using Nintedanib for Esophagogastric CancerElizabeth Won, Azfar Basunia, Walid K Chatila, et al.Pageof 9